Creso Pharma Limited
COPHF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$32,782 | $0 | $0 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | $0 | $1,949 | $0 | $0 |
| Operating Cash Flow | $0 | -$30,833 | -$22,378 | -$9,622 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$313 | -$348 | -$454 | -$429 |
| Net Acquisitions | $232 | $0 | -$494 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$403 |
| Other Inv. Act. | $0 | -$1,936 | -$423 | $0 |
| Investing Cash Flow | -$81 | -$2,284 | -$1,371 | -$832 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,238 | $4,588 | $0 | $0 |
| Stock Issued | $5,124 | $9,962 | $26,528 | $12,474 |
| Stock Repurch. | -$699 | -$622 | -$1,434 | -$1,722 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,318 | -$117 | $24,893 | $13,650 |
| Financing Cash Flow | $7,505 | $13,811 | $24,893 | $13,650 |
| Forex Effect | $21 | -$17 | -$7 | $50 |
| Net Chg. in Cash | -$696 | -$5,796 | $1,137 | $3,247 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,388 | $7,184 | $6,047 | $2,800 |
| End Cash | $692 | $1,388 | $7,184 | $6,047 |
| Free Cash Flow | -$8,454 | -$31,181 | -$22,832 | -$10,051 |